HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Congenital Aural Atresia

A hereditary autosomal dominant ear abnormality where defects in structures of the AUDITORY CANAL or MIDDLE EAR result in CONDUCTIVE HEARING LOSS. Decreased odor sensitivity and discrimination may also occur in some patients due to hypoplasia of the OLFACTORY BULB. Mutations in the TSHZ1 gene have been identified. OMIM: 607842
Also Known As:
Aural Atresia, Congenital
Networked: 61 relevant articles (5 outcomes, 10 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Pathologic Constriction (Stenosis)
2. Congenital Microtia
3. Hearing Loss (Hearing Impairment)
4. Otosclerosis
5. Atrioventricular Block

Experts

1. Yamasoba, Tatsuya: 3 articles (11/2015 - 12/2011)
2. Zhao, S Q: 2 articles (04/2021 - 10/2016)
3. Chen, Peiwei: 2 articles (02/2021 - 12/2020)
4. Gao, Mengdie: 2 articles (02/2021 - 12/2020)
5. Liu, Yujie: 2 articles (02/2021 - 12/2020)
6. Yang, Jinsong: 2 articles (02/2021 - 12/2020)
7. Zhao, Shouqin: 2 articles (02/2021 - 12/2020)
8. Iwasaki, Satoshi: 2 articles (01/2021 - 09/2011)
9. Kobayashi, Toshimitsu: 2 articles (06/2020 - 09/2011)
10. Kesser, Bradley W: 2 articles (02/2018 - 02/2011)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Congenital Aural Atresia:
1. TitaniumIBA
2. ArgonIBA
3. polyvinyl alcohol formaldehyde foamIBA
4. baysilon (polydimethylsiloxane)IBA
5. trans-crotonin (CTN)IBA
6. MedporIBA
7. Growth Hormone (Somatotropin)IBA
8. SolutionsIBA
9. PlasticsIBA

Therapies and Procedures

1. Ossicular Prosthesis (TORP)
2. Hearing Aids (Hearing Aid)
3. Lasers (Laser)
4. Surgical Instruments (Clip)
5. Tympanoplasty